pt288-aurka antibodies Search Results


96
Cell Signaling Technology Inc pt288 aurka
Pt288 Aurka, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pt288 aurka/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
pt288 aurka - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Novus Biologicals pt288-aurka antibodies
Pt288 Aurka Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pt288-aurka antibodies/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
pt288-aurka antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc anti-aurora a kinase-pt288
Anti Aurora A Kinase Pt288, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-aurora a kinase-pt288/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
anti-aurora a kinase-pt288 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc anti-pt288aurka
Inhibition of Aurora Kinase A (AURKA) limits bisphenol-mediated spindle pole disruption. (A) Western blot (5 replicates) of phosphorylated/active AURKA <t>(pT288AURKA),</t> total AURKA and control β-tubulin protein levels in control, BPA or BPF-treated oocytes lysates (50 oocytes/lane) either alone or together with MLN8337. (B) The expression levels of active pT288AURKA compared between treatment groups and the control (media alone), which was normalized to 1.0. (C) Representative fluorescence microscopy images of oocytes from control as well as BPA or BPF treatment (50μg/ml) groups following a 4h culture with or without a specific AURKA inhibitor, MLN8237 (500nM). Oocytes were double labeled with anti-acetylated tubulin (green) and pT288 AURKA (red). Chromosomes (grey) were counterstained with DAPI. Scale bar: 10μm. Quantitative analysis (mean ± s.e.m) of the (D, F) meiotic spindle length (pole-to-pole distance) and (E, G) average spindle pole width assessed in BPA or BPF-treated oocytes (50-80 total oocytes per group, from 3 replicates) –either alone (solid bars) or together with MLN8237 (hatched bars). Control oocytes were cultured in either media alone or with MLN8237. Different letters denote statistical significance at P<0.05.
Anti Pt288aurka, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pt288aurka/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
anti-pt288aurka - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti aurka pt288 aurkb pt232 aurkc t198
Inhibition of Aurora Kinase A (AURKA) limits bisphenol-mediated spindle pole disruption. (A) Western blot (5 replicates) of phosphorylated/active AURKA <t>(pT288AURKA),</t> total AURKA and control β-tubulin protein levels in control, BPA or BPF-treated oocytes lysates (50 oocytes/lane) either alone or together with MLN8337. (B) The expression levels of active pT288AURKA compared between treatment groups and the control (media alone), which was normalized to 1.0. (C) Representative fluorescence microscopy images of oocytes from control as well as BPA or BPF treatment (50μg/ml) groups following a 4h culture with or without a specific AURKA inhibitor, MLN8237 (500nM). Oocytes were double labeled with anti-acetylated tubulin (green) and pT288 AURKA (red). Chromosomes (grey) were counterstained with DAPI. Scale bar: 10μm. Quantitative analysis (mean ± s.e.m) of the (D, F) meiotic spindle length (pole-to-pole distance) and (E, G) average spindle pole width assessed in BPA or BPF-treated oocytes (50-80 total oocytes per group, from 3 replicates) –either alone (solid bars) or together with MLN8237 (hatched bars). Control oocytes were cultured in either media alone or with MLN8237. Different letters denote statistical significance at P<0.05.
Anti Aurka Pt288 Aurkb Pt232 Aurkc T198, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti aurka pt288 aurkb pt232 aurkc t198/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti aurka pt288 aurkb pt232 aurkc t198 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

N/A
AURKA pT288 Antibody is a Rabbit Polyclonal antibody against AURKA pT288 The protein encoded by this gene is a cell cycle regulated kinase that appears to be involved in microtubule formation and or stabilization at
  Buy from Supplier

Image Search Results


Inhibition of Aurora Kinase A (AURKA) limits bisphenol-mediated spindle pole disruption. (A) Western blot (5 replicates) of phosphorylated/active AURKA (pT288AURKA), total AURKA and control β-tubulin protein levels in control, BPA or BPF-treated oocytes lysates (50 oocytes/lane) either alone or together with MLN8337. (B) The expression levels of active pT288AURKA compared between treatment groups and the control (media alone), which was normalized to 1.0. (C) Representative fluorescence microscopy images of oocytes from control as well as BPA or BPF treatment (50μg/ml) groups following a 4h culture with or without a specific AURKA inhibitor, MLN8237 (500nM). Oocytes were double labeled with anti-acetylated tubulin (green) and pT288 AURKA (red). Chromosomes (grey) were counterstained with DAPI. Scale bar: 10μm. Quantitative analysis (mean ± s.e.m) of the (D, F) meiotic spindle length (pole-to-pole distance) and (E, G) average spindle pole width assessed in BPA or BPF-treated oocytes (50-80 total oocytes per group, from 3 replicates) –either alone (solid bars) or together with MLN8237 (hatched bars). Control oocytes were cultured in either media alone or with MLN8237. Different letters denote statistical significance at P<0.05.

Journal: Reproduction (Cambridge, England)

Article Title: Mechanisms underlying disruption of oocyte spindle stability by bisphenol compounds

doi: 10.1530/REP-19-0494

Figure Lengend Snippet: Inhibition of Aurora Kinase A (AURKA) limits bisphenol-mediated spindle pole disruption. (A) Western blot (5 replicates) of phosphorylated/active AURKA (pT288AURKA), total AURKA and control β-tubulin protein levels in control, BPA or BPF-treated oocytes lysates (50 oocytes/lane) either alone or together with MLN8337. (B) The expression levels of active pT288AURKA compared between treatment groups and the control (media alone), which was normalized to 1.0. (C) Representative fluorescence microscopy images of oocytes from control as well as BPA or BPF treatment (50μg/ml) groups following a 4h culture with or without a specific AURKA inhibitor, MLN8237 (500nM). Oocytes were double labeled with anti-acetylated tubulin (green) and pT288 AURKA (red). Chromosomes (grey) were counterstained with DAPI. Scale bar: 10μm. Quantitative analysis (mean ± s.e.m) of the (D, F) meiotic spindle length (pole-to-pole distance) and (E, G) average spindle pole width assessed in BPA or BPF-treated oocytes (50-80 total oocytes per group, from 3 replicates) –either alone (solid bars) or together with MLN8237 (hatched bars). Control oocytes were cultured in either media alone or with MLN8237. Different letters denote statistical significance at P<0.05.

Article Snippet: Immunofluorescence analysis Oocytes were fixed and immunolabeled with specific antibodies as previously described ( Baumann & Viveiros 2015 ) including, anti-TPX2 (1/500; Novus Biological, Centennial, CO), anti-PCNT (1/1000; BD Biosciences, San Jose, CA or Covance, Princeton, NJ), anti-acetylated α-tubulin (1/1000; Sigma Aldrich) and anti-pT288AURKA (1/1000; Cell Signaling Technology, Beverly, MA).

Techniques: Inhibition, Western Blot, Expressing, Fluorescence, Microscopy, Labeling, Cell Culture